Free Shipping on purchases over €100

Sesderma Pack Sesderma Azelac Ru Luminous Fluid Spf 50, 50 Ml

Luminous fluid that prevents and reduces blemishes, evens the tone and corrects the pigmentation background. Includes sun protection. 2 x 50 ml.

SKU: SE4202066220996
-42%
54.50
€93.90
€109.00
/100ml

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

INFO AND TECHNICAL SPECIFICATIONS

It is a luminous facial fluid with sun protection and liposome depigmenting active ingredients that improve the appearance of blemishes and homogenise skin tone. It performs a triple depigmenting action: It effectively lightens, loosens and reduces melanin production. Reduces, stimulates the dispersion of melanin and eliminates excess melanin. Prevents and slows down the appearance of spots.

Azelac Ru Brightening Depigmenting Fluid SPF 50 is composed of Tranexamic Acid, a powerful depigmenting agent that has been shown to reduce vascular melasma caused by excessive exposure to the sun's rays. This powerful active ingredient acts at three levels: it inhibits the expression of ET-1, thus modulating melanocyte hyperactivity, it acts on the angiogenesis process by blocking vascular endothelial growth factors (VEGF), and finally, it has a moisturising action that enhances the skin's barrier effect, reducing melanin formation/pigment reduction.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Sesderma S.L.
  • Vendor address: Calle Mar Mediterrania (Polígono Industrial Torre del Rector), 5-9, 08130 Santa Perpètua de Mogoda, Barcelona, España
  • Phone number: +34 935 747 440
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.